Security · CUSIP 28249U105
EIGER BIOPHARMACEUTICALS INC
COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 43
Added / reduced
0 / 0
net -18.5M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q1 2024
Nothing to show.
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| AMERIPRISE FINANCIAL INC | Sold out | -7,505,539 | -100.0% |
| Propel Bio Management, LLC | Sold out | -4,391,432 | -100.0% |
| 683 Capital Management, LLC | Sold out | -2,100,000 | -100.0% |
| VANGUARD GROUP INC | Sold out | -1,820,767 | -100.0% |
| BlackRock Inc. | Sold out | -583,730 | -100.0% |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -379,707 | -100.0% |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -344,210 | -100.0% |
| RBF Capital, LLC | Sold out | -338,733 | -100.0% |
| ACADIAN ASSET MANAGEMENT LLC | Sold out | -174,088 | -100.0% |
| STATE STREET CORP | Sold out | -146,781 | -100.0% |
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.